Oct 09, 2014 at 14:24 | Source: CNBC-TV18
Zensar Technologies has signed a multi-million dollar deal with a leading UK-based high street retailer. The new engagement involves a managed services portfolio consolidation.
Oct 08, 2014 at 18:14 | Source: PTI
The Pune-headquartered firm has been managing multiple systems for the retailer for 7 years and the new engagement involves a managed services portfolio consolidation, it said in a statement.
Sep 29, 2014 at 11:18 | Source: CNBC-TV18
On the partnership with New Generation Power he said it will lead to high growth trajectory. The deal size is worth USD 207 million and equity component of the deal is seen at USD 60 million, said Valecha.
Sep 25, 2014 at 21:24 | Source: PTI
On September 17, the commodity markets regulator FMC had said the exchange can launch new contracts for three months January, February and March of 2015 after if it signs a fresh technology deal with FTIL.
Sep 24, 2014 at 15:11 | Source: CNBC-TV18
Modi will be in the United States to sell the India story. He will be trying to convince strategic as well as foreign institutional investors that there is more juice left in the Indian market. FIIs have been responsible for driving the Indian equity market to new record highs.
Sep 22, 2014 at 18:00 | Source: Reuters
The fees are equivalent to 1.2 percent of the total deal, which reached USD 25 billion after underwriters exercised an option to sell additional shares.
Sep 21, 2014 at 18:34 | Source: PTI
The proposed norms, which are currently at draft stage and are going through consultations, would considerably enhance the disclosure requirements by stock brokers and can subject them to tightened regulations with regard to related party transactions and audit of their books and other dealings.
Sep 17, 2014 at 21:37 | Source: CNBC-TV18
Sale of bad loans by banks to ARCs has come to a standstill. The villain, bankers and ARCs says are the new RBI rules that require ARCs to have a higher stake in the bad loans being bought. Unless banks can really drop the price at which they sell bad loans to ARCs, no deals may get done and the Q2 results could show higher NPLs.
Sep 15, 2014 at 11:00 | Source: Moneycontrol.com
US-based drug maker Gilead Sciences may join hands with atleast five Indian generic pharmaceutical companies for manufacturing and selling cheaper versions of its new hepatitis C medicines.
Sep 09, 2014 at 15:22 | Source: PTI
Rakuten said the all-cash deal would give it access to 2.5 million new customers in the United States, Canada, South Korea and China.